Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 755

1.

Transient portal vein thrombosis in liver cirrhosis.

Qi X, Guo X, Yoshida EM, Méndez-Sánchez N, De Stefano V, Tacke F, Mancuso A, Sugawara Y, Yang SS, Teschke R, Arora A, Valla DC.

BMC Med. 2018 Jun 5;16(1):83. doi: 10.1186/s12916-018-1069-8. Review.

2.

In vivo wide-field calcium imaging of mouse thalamocortical synapses with an 8 K ultra-high-definition camera.

Yoshida E, Terada SI, Tanaka YH, Kobayashi K, Ohkura M, Nakai J, Matsuzaki M.

Sci Rep. 2018 May 29;8(1):8324. doi: 10.1038/s41598-018-26566-3.

3.

Pool-based genome-wide association study identified novel candidate regions on BTA9 and 14 for oleic acid percentage in Japanese Black cattle.

Kawaguchi F, Kigoshi H, Nakajima A, Matsumoto Y, Uemoto Y, Fukushima M, Yoshida E, Iwamoto E, Akiyama T, Kohama N, Kobayashi E, Honda T, Oyama K, Mannen H, Sasazaki S.

Anim Sci J. 2018 May 17. doi: 10.1111/asj.13035. [Epub ahead of print]

PMID:
29770990
4.

Utilizing sensory prediction errors for movement intention decoding: A new methodology.

Ganesh G, Nakamura K, Saetia S, Tobar AM, Yoshida E, Ando H, Yoshimura N, Koike Y.

Sci Adv. 2018 May 9;4(5):eaaq0183. doi: 10.1126/sciadv.aaq0183. eCollection 2018 May.

5.

Impact of Indoxyl Sulfate on Coronary Plaques in Patients on Hemodialysis.

Asami M, Tanabe K, Ito S, Yoshida E, Aoki J, Tanimoto S, Horiuchi Y, Yoshida M.

Int Heart J. 2018 May 30;59(3):489-496. doi: 10.1536/ihj.17-351. Epub 2018 May 9.

6.

Development of a novel salivary gland cancer lymph node staging system.

Aro K, Ho AS, Luu M, Kim S, Tighiouart M, Clair JM, Yoshida EJ, Shiao SL, Leivo I, Zumsteg ZS.

Cancer. 2018 May 9. doi: 10.1002/cncr.31535. [Epub ahead of print]

PMID:
29742277
7.

Sofosbuvir-Based Therapy in the Pre-Liver Transplant Setting: The Canadian National Experience.

Al-Judaibi B, Thomas B, Wong P, Benmassaoud A, Chen JH, Dokus MK, Hussaini T, Bilodeau M, Burak KW, Marotta P, Yoshida EM.

Ann Hepatol. 2018 May-June;17(3):437-443. doi: 10.5604/01.3001.0011.7388. Epub 2018 Apr 9.

8.

Transplantation of a Liver Allograft From a Hepatitis C Virus Seropositive Donor With Previous Sustained Virologic Response to an Uninfected Recipient Suffering Steroid Refractory Acute Graft Rejection With No Evidence of HCV Transmission.

Mitchell RA, Hussaini T, Yau AH, Krajden M, Wright AJ, Scudamore CH, Marquez Azalgara V, Erb SR, Yoshida EM.

Transplant Direct. 2018 Feb 2;4(3):e347. doi: 10.1097/TXD.0000000000000763. eCollection 2018 Mar.

9.

Editorial: hepatocellular carcinoma as a consequence of hepatitis C direct-acting anti-virals-the great urban myth of hepatology.

Hussaini T, Zhu J, Yoshida EM.

Aliment Pharmacol Ther. 2018 May;47(10):1418-1419. doi: 10.1111/apt.14634. No abstract available.

PMID:
29676006
10.

Impact of Sofosbuvir-Based Regimens for the Treatment of Hepatitis C After Liver Transplant on Renal Function: Results of a Canadian National Retrospective Study.

Faisal N, Bilodeau M, Aljudaibi B, Hirch G, Yoshida EM, Hussaini T, Ghali MP, Congly SE, Ma MM, Lilly LB.

Exp Clin Transplant. 2018 Apr 4. doi: 10.6002/ect.2017.0201. [Epub ahead of print]

11.

Tacrolimus and Mycophenolate Mofetil as Second-Line Therapies for Pediatric Patients with Autoimmune Hepatitis.

Efe C, Taii HA, Ytting H, Aehling N, Bhanji RA, Hagström H, Purnak T, Muratori L, Werner M, Muratori P, Klintman D, Schiano TD, Montano-Loza AJ, Berg T, Larsen FS, Alkhouri N, Ozaslan E, Heneghan MA, Yoshida EM, Wahlin S.

Dig Dis Sci. 2018 May;63(5):1348-1354. doi: 10.1007/s10620-018-5011-x. Epub 2018 Mar 22.

PMID:
29569003
12.

Let's Talk About B: Barriers to Hepatitis B Screening and Vaccination Among Asian and South Asian Immigrants in British Columbia.

Zibrik L, Huang A, Wong V, Novak Lauscher H, Choo Q, Yoshida EM, Ho K.

J Racial Ethn Health Disparities. 2018 Mar 19. doi: 10.1007/s40615-018-0483-0. [Epub ahead of print]

PMID:
29557047
13.

Insights into the hepatocellular carcinoma patient journey: results of the first global quality of life survey.

Gill J, Baiceanu A, Clark PJ, Langford A, Latiff J, Yang PM, Yoshida EM, Kanavos P.

Future Oncol. 2018 Mar 15. doi: 10.2217/fon-2017-0715. [Epub ahead of print]

14.

Hyperactivation of Nrf2 leads to hypoplasia of bone in vivo.

Yoshida E, Suzuki T, Morita M, Taguchi K, Tsuchida K, Motohashi H, Doita M, Yamamoto M.

Genes Cells. 2018 May;23(5):386-392. doi: 10.1111/gtc.12579. Epub 2018 Mar 15.

PMID:
29542224
15.

The Value of Monitoring Clinical Decision Support Interventions.

Yoshida E, Fei S, Bavuso K, Lagor C, Maviglia S.

Appl Clin Inform. 2018 Jan;9(1):163-173. doi: 10.1055/s-0038-1632397. Epub 2018 Mar 7.

PMID:
29514353
16.

Application of 80-kVp scan and raw data-based iterative reconstruction for reduced iodine load abdominal-pelvic CT in patients at risk of contrast-induced nephropathy referred for oncological assessment: effects on radiation dose, image quality and renal function.

Nagayama Y, Tanoue S, Tsuji A, Urata J, Furusawa M, Oda S, Nakaura T, Utsunomiya D, Yoshida E, Yoshida M, Kidoh M, Tateishi M, Yamashita Y.

Br J Radiol. 2018 May;91(1085):20170632. doi: 10.1259/bjr.20170632. Epub 2018 Mar 2.

PMID:
29470108
17.

Postoperative chemoradiotherapy in patients with head and neck cancer aged 70 or older with positive margins or extranodal extension and the influence of nodal classification.

Yoshida EJ, Luu M, David JM, Kim S, Mita A, Scher K, Shiao SL, Tighiouart M, Ho AS, Zumsteg ZS.

Head Neck. 2018 Jun;40(6):1228-1236. doi: 10.1002/hed.25100. Epub 2018 Feb 8.

PMID:
29417700
18.

Evaluation of an S-system root-finding method for estimating parameters in a metabolic reaction model.

Iwata M, Miyawaki-Kuwakado A, Yoshida E, Komori S, Shiraishi F.

Math Biosci. 2018 Jul;301:21-31. doi: 10.1016/j.mbs.2018.01.010. Epub 2018 Feb 2.

PMID:
29410225
19.

Population structure and antimicrobial susceptibility of Paenibacillus larvae isolates from American foulbrood cases in Apis mellifera in Japan.

Ueno Y, Yoshida E, Misumi W, Watando E, Suzuki K, Hirai Y, Okura M, Osaki M, Katsuda K, Takamatsu D.

Environ Microbiol Rep. 2018 Apr;10(2):210-216. doi: 10.1111/1758-2229.12623. Epub 2018 Feb 23.

PMID:
29393586
20.

Transplantation as disease modifying therapy in adults with inherited metabolic disorders.

Sirrs S, Hannah-Shmouni F, Nantel S, Neuberger J, Yoshida EM.

J Inherit Metab Dis. 2018 Feb 1. doi: 10.1007/s10545-018-0141-z. [Epub ahead of print] Review.

PMID:
29392586
21.

A genome-wide association study for fat-related traits computed by image analysis in Japanese Black cattle.

Nakajima A, Kawaguchi F, Uemoto Y, Fukushima M, Yoshida E, Iwamoto E, Akiyama T, Kohama N, Kobayashi E, Honda T, Oyama K, Mannen H, Sasazaki S.

Anim Sci J. 2018 May;89(5):743-751. doi: 10.1111/asj.12987. Epub 2018 Jan 30.

PMID:
29380492
22.

Clinical characteristics and outcomes of traditional Chinese medicine-induced liver injury: a systematic review.

Wang R, Qi X, Yoshida EM, Méndez-Sánchez N, Teschke R, Sun M, Liu X, Su C, Deng J, Deng H, Hou F, Guo X.

Expert Rev Gastroenterol Hepatol. 2018 Apr;12(4):425-434. doi: 10.1080/17474124.2018.1427581. Epub 2018 Jan 18.

PMID:
29323538
23.

Annals of Hepatology: Viewpoints from Afar.

Yoshida EM, Qi X.

Ann Hepatol. 2018 January-February;17(1):4-7. doi: 10.5604/01.3001.0010.7528. No abstract available.

24.

Primary Biliary Cholangitis in British Columbia First Nations: Clinical features and discovery of novel genetic susceptibility loci.

Asuri S, McIntosh S, Taylor V, Rokeby A, Kelly J, Shumansky K, Field LL, Yoshida EM, Arbour L.

Liver Int. 2018 May;38(5):940-948. doi: 10.1111/liv.13686. Epub 2018 Jan 23.

PMID:
29297981
25.

Residual symptoms and disease burden among patients with rheumatoid arthritis in remission or low disease activity: a systematic literature review.

Ishida M, Kuroiwa Y, Yoshida E, Sato M, Krupa D, Henry N, Ikeda K, Kaneko Y.

Mod Rheumatol. 2018 Jan 11:1-11. doi: 10.1080/14397595.2017.1416940. [Epub ahead of print]

PMID:
29251034
26.

Ischemic stroke in liver cirrhosis: epidemiology, risk factors, and in-hospital outcomes.

Zhang X, Qi X, Yoshida EM, Méndez-Sánchez N, Hou F, Deng H, Wang X, Qiu J, He C, Wang S, Guo X.

Eur J Gastroenterol Hepatol. 2018 Feb;30(2):233-240. doi: 10.1097/MEG.0000000000001011.

PMID:
29189394
27.

Supersonic shear imaging for the diagnosis of liver fibrosis and portal hypertension in liver diseases: a meta-analysis.

Deng H, Qi X, Zhang T, Qi X, Yoshida EM, Guo X.

Expert Rev Gastroenterol Hepatol. 2018 Jan;12(1):91-98. doi: 10.1080/17474124.2018.1412257. Epub 2017 Dec 8.

PMID:
29186994
28.

Development of a dual-ended readout detector with segmented crystal bars made using a subsurface laser engraving technique.

Mohammadi A, Yoshida E, Nishikido F, Nitta M, Shimizu K, Sakai T, Yamaya T.

Phys Med Biol. 2018 Jan 11;63(2):025019. doi: 10.1088/1361-6560/aa9d03.

PMID:
29176052
29.

Synergistic cytotoxicity caused by forming a complex of copper and 2,9-dimethyl-1,10-phenanthroline in cultured vascular endothelial cells.

Nakamura T, Yoshida E, Fujie T, Ogata F, Yamamoto C, Kawasaki N, Kaji T.

J Toxicol Sci. 2017;42(6):683-687. doi: 10.2131/jts.42.683.

30.

The Cedar Project: mortality among young Indigenous people who use drugs in British Columbia.

Jongbloed K, Pearce ME, Pooyak S, Zamar D, Thomas V, Demerais L, Christian WM, Henderson E, Sharma R, Blair AH, Yoshida EM, Schechter MT, Spittal PM; Cedar Project Partnership.

CMAJ. 2017 Nov 6;189(44):E1352-E1359. doi: 10.1503/cmaj.160778.

31.

Safety, efficacy and pharmacodynamics of vesatolimod (GS-9620) in virally suppressed patients with chronic hepatitis B.

Janssen HLA, Brunetto MR, Kim YJ, Ferrari C, Massetto B, Nguyen AH, Joshi A, Woo J, Lau AH, Gaggar A, Subramanian GM, Yoshida EM, Ahn SH, Tsai NCS, Fung S, Gane EJ.

J Hepatol. 2018 Mar;68(3):431-440. doi: 10.1016/j.jhep.2017.10.027. Epub 2017 Dec 11.

PMID:
29104121
32.

Facility Volume and Survival in Nasopharyngeal Carcinoma.

Yoshida EJ, Luu M, David JM, Kim S, Mita A, Scher K, Shiao SL, Tighiouart M, Lee NY, Ho AS, Zumsteg ZS.

Int J Radiat Oncol Biol Phys. 2018 Feb 1;100(2):408-417. doi: 10.1016/j.ijrobp.2017.09.038. Epub 2017 Sep 28.

PMID:
29100787
33.

Promoter-level transcriptome in primary lesions of endometrial cancer identified biomarkers associated with lymph node metastasis.

Yoshida E, Terao Y, Hayashi N, Mogushi K, Arakawa A, Tanaka Y, Ito Y, Ohmiya H, Hayashizaki Y, Takeda S, Itoh M, Kawaji H.

Sci Rep. 2017 Oct 26;7(1):14160. doi: 10.1038/s41598-017-14418-5.

34.

Risk estimation for intervertebral disc pressure through musculoskeletal joint reaction force simulation.

Imamura Y, Ayusawa K, Yoshida E.

Conf Proc IEEE Eng Med Biol Soc. 2017 Jul;2017:1636-1639. doi: 10.1109/EMBC.2017.8037153.

PMID:
29060197
35.

Development of a fully automated chemiluminescence immunoassay for urine monomeric laminin-γ2 as a promising diagnostic tool of non-muscle invasive bladder cancer.

Nakagawa M, Karashima T, Kamada M, Yoshida E, Yoshimura T, Nojima M, Inoue K, Shuin T, Seiki M, Koshikawa N.

Biomark Res. 2017 Oct 13;5:29. doi: 10.1186/s40364-017-0109-4. eCollection 2017.

36.

Glecaprevir and Pibrentasvir in Patients with HCV and Severe Renal Impairment.

Gane E, Lawitz E, Pugatch D, Papatheodoridis G, Bräu N, Brown A, Pol S, Leroy V, Persico M, Moreno C, Colombo M, Yoshida EM, Nelson DR, Collins C, Lei Y, Kosloski M, Mensa FJ.

N Engl J Med. 2017 Oct 12;377(15):1448-1455. doi: 10.1056/NEJMoa1704053.

37.

Cost-effectiveness analysis of treatment with non-curative or palliative intent for hepatocellular carcinoma in the real-world setting.

Thein HH, Qiao Y, Zaheen A, Jembere N, Sapisochin G, Chan KKW, Yoshida EM, Earle CC.

PLoS One. 2017 Oct 10;12(10):e0185198. doi: 10.1371/journal.pone.0185198. eCollection 2017.

39.

Predictors of survival in head and neck mucosal melanoma.

Schmidt MQ, David J, Yoshida EJ, Scher K, Mita A, Shiao SL, Ho AS, Zumsteg ZS.

Oral Oncol. 2017 Oct;73:36-42. doi: 10.1016/j.oraloncology.2017.08.002. Epub 2017 Aug 10.

PMID:
28939074
40.

Data integration from pathology slides for quantitative imaging of multiple cell types within the tumor immune cell infiltrate.

Ma Z, Shiao SL, Yoshida EJ, Swartwood S, Huang F, Doche ME, Chung AP, Knudsen BS, Gertych A.

Diagn Pathol. 2017 Sep 18;12(1):69. doi: 10.1186/s13000-017-0658-8.

41.

Copper diethyldithiocarbamate as an inhibitor of tissue plasminogen activator synthesis in cultured human coronary endothelial cells.

Fujie T, Okino S, Yoshida E, Yamamoto C, Naka H, Kaji T.

J Toxicol Sci. 2017;42(5):553-558. doi: 10.2131/jts.42.553.

42.

MRI compatibility study of an integrated PET/RF-coil prototype system at 3T.

Akram MSH, Obata T, Suga M, Nishikido F, Yoshida E, Saito K, Yamaya T.

J Magn Reson. 2017 Oct;283:62-70. doi: 10.1016/j.jmr.2017.08.010. Epub 2017 Aug 31.

PMID:
28881235
43.

Immunosuppression Practices in Liver Transplantation: A Survey of North American Centers.

Hussaini T, Turgeon RD, Partovi N, Erb SR, Scudamore CH, Yoshida EM.

Exp Clin Transplant. 2017 Aug 28. doi: 10.6002/ect.2017.0096. [Epub ahead of print]

44.

Exposure to Electrophiles Impairs Reactive Persulfide-Dependent Redox Signaling in Neuronal Cells.

Ihara H, Kasamatsu S, Kitamura A, Nishimura A, Tsutsuki H, Ida T, Ishizaki K, Toyama T, Yoshida E, Abdul Hamid H, Jung M, Matsunaga T, Fujii S, Sawa T, Nishida M, Kumagai Y, Akaike T.

Chem Res Toxicol. 2017 Sep 18;30(9):1673-1684. doi: 10.1021/acs.chemrestox.7b00120. Epub 2017 Sep 7.

PMID:
28837763
45.

Combined high-intensity local treatment and systemic therapy in metastatic head and neck squamous cell carcinoma: An analysis of the National Cancer Data Base.

Zumsteg ZS, Luu M, Yoshida EJ, Kim S, Tighiouart M, David JM, Shiao SL, Mita AC, Scher KS, Sherman EJ, Lee NY, Ho AS.

Cancer. 2017 Dec 1;123(23):4583-4593. doi: 10.1002/cncr.30933. Epub 2017 Aug 17.

PMID:
28817183
46.

Simulation-based design for robotic care device: Optimizing trajectory of transfer support robot.

Imamura Y, Ayusawa K, Endo Y, Yoshida E.

IEEE Int Conf Rehabil Robot. 2017 Jul;2017:851-856. doi: 10.1109/ICORR.2017.8009355.

PMID:
28813927
47.

Transplanting Kidney Allografts from Hepatitis C Infected Donors into Hepatitis C Uninfected Recipients: Re-Thinking the Thinker Trial.

Hussaini T, Yoshida EM.

Ann Hepatol. 2017 Sep-Oct;16(5):702-703. doi: 10.5604/01.3001.0010.2708.

48.

Safety and efficacy of a fixed-dose combination regimen of grazoprevir, ruzasvir, and uprifosbuvir with or without ribavirin in participants with and without cirrhosis with chronic hepatitis C virus genotype 1, 2, or 3 infection (C-CREST-1 and C-CREST-2, part B): two randomised, phase 2, open-label trials.

Lawitz E, Buti M, Vierling JM, Almasio PL, Bruno S, Ruane PJ, Hassanein TI, Muellhaupt B, Pearlman B, Jancoriene L, Gao W, Huang HC, Shepherd A, Tannenbaum B, Fernsler D, Li JJ, Grandhi A, Liu H, Su FH, Wan S, Dutko FJ, Nguyen BT, Wahl J, Robertson MN, Barr E, Yeh WW, Plank RM, Butterton JR, Yoshida EM.

Lancet Gastroenterol Hepatol. 2017 Nov;2(11):814-823. doi: 10.1016/S2468-1253(17)30163-2. Epub 2017 Aug 10.

PMID:
28802814
49.

Cost-effectiveness analysis of potentially curative and combination treatments for hepatocellular carcinoma with person-level data in a Canadian setting.

Thein HH, Isaranuwatchai W, Qiao Y, Wong K, Sapisochin G, Chan KKW, Yoshida EM, Earle CC.

Cancer Med. 2017 Sep;6(9):2017-2033. doi: 10.1002/cam4.1119. Epub 2017 Aug 8.

50.

Editorial: hepatitis C direct acting anti-viral agents and the kidney.

Hussaini T, Yoshida EM.

Aliment Pharmacol Ther. 2017 Aug;46(3):378-379. doi: 10.1111/apt.14161. No abstract available.

PMID:
28677286

Supplemental Content

Loading ...
Support Center